#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4677164	F	Antitumor activity against human AMO1 cells xenografted in CB-17 SCID mouse assessed as time to reach tumor volume of 500 mm3 at 25 mg/kg, iv administered as bolus dose for 5 consecutive days	Homo sapiens	2		organism-based format	Scientific Literature
2.	ALA4677165	F	Antitumor activity against human AMO1 cells xenografted in CB-17 SCID mouse assessed as time to reach tumor volume of 500 mm3 at 50 mg/kg, iv administered as bolus dose for 5 consecutive days	Homo sapiens	2		organism-based format	Scientific Literature
3.	ALA4677166	F	Antitumor activity against human AMO1 xenografted in CB-17 SCID mouse assessed as tumor growth suppression at 50 mg/kg, iv administered for 5 consecutive days measured after 5 weeks	Homo sapiens	1		organism-based format	Scientific Literature
4.	ALA4677167	F	Antitumor activity against human AMO1 xenografted in CB-17 SCID mouse assessed as tumor growth suppression at 25 mg/kg, iv administered for 5 consecutive days and measured post-last dose	Homo sapiens	1		organism-based format	Scientific Literature
5.	ALA4677173	F	Antitumor activity against human AMO1 cells xenografted in CB-17 SCID mouse assessed as maximum tumor growth inhibition at 50 mg/kg, iv administered as bolus dose for 5 consecutive days measured on day 2 relative to control	Homo sapiens	2		organism-based format	Scientific Literature
6.	ALA4677174	F	Antitumor activity against human AMO1 cells xenografted in CB-17 SCID mouse assessed as maximum tumor growth inhibition at 25 mg/kg, iv administered as bolus dose for 5 consecutive days measured on day 2 relative to control	Homo sapiens	1		organism-based format	Scientific Literature
7.	ALA4677178	F	Antitumor activity against human AMO1 cells xenografted in CB-17 SCID mouse assessed as tumor growth inhibition at 50 mg/kg, iv for 5 days measured on day 7 relative to control	Homo sapiens	2		organism-based format	Scientific Literature
8.	ALA4677179	F	Antitumor activity against human AMO1 cells xenografted in CB-17 SCID mouse assessed as tumor growth inhibition at 25 mg/kg, iv for 5 days measured on day7 relative to control	Homo sapiens	2		organism-based format	Scientific Literature
9.	ALA4677181	F	Induction of apoptosis in human AMO1 cells xenografted in CB-17 SCID mouse assessed as increase in cleaved PARP level at 25 to 50 mg/kg, iv administered as bolus dose measured after 30 hrs by immunodetection analysis	Homo sapiens	2		organism-based format	Scientific Literature
10.	ALA4677182	F	Induction of apoptosis in human AMO1 cells xenografted in CB-17 SCID mouse assessed as increase in cleaved PARP level administered intravenously as bolus dose measured after 6 to 16 hrs by immunodetection analysis	Homo sapiens	2		organism-based format	Scientific Literature
11.	ALA4677183	F	Induction of apoptosis in human AMO1 cells xenografted in CB-17 SCID mouse assessed as increase in cleaved PARP level at 25 to 50 mg/kg, iv administered as bolus dose measured after 6 hrs by immunodetection analysis	Homo sapiens	2		organism-based format	Scientific Literature
12.	ALA4677187	F	Antiproliferative activity against human NCI-H929 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay	Homo sapiens	68		cell-based format	Scientific Literature
13.	ALA4677188	B	Inhibition of C-terminal TQ5WS-labelled QWAREIGAQLRRMADDLNAQY binding to human C-terminal Cy5-labelled Mcl-1 V321C/C286S mutant (171 to 321 residue) incubated for 2 hrs by fluorescence polarization analysis	Homo sapiens	68		assay format	Scientific Literature